Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
JARID2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KIF3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GNB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GTF3C3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHKB-CPT1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXOC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CPT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPD52L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RC3H2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FANCI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMCHD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DOCK7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FHL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LANCL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on